Literature DB >> 32425298

Covid-19 during pregnancy: A case series from an universally tested population from the north of Portugal.

Mariana Dória1, Catarina Peixinho2, Mafalda Laranjo2, Ana Mesquita Varejão2, Pedro Tiago Silva2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32425298      PMCID: PMC7227580          DOI: 10.1016/j.ejogrb.2020.05.029

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


× No keyword cloud information.
Dear Editor, The case series published so far are quite heterogeneous [[1], [2], [3]]. Some series occurred during the beginning of the pandemic, when the disease was largely unknown, others occurred during the peak of mortality and fear of disease spread among the community and healthcare professionals; some series pertained to symptomatic women in settings where testing was only performed in cases with moderate to severe symptoms and others also to asymptomatic women in settings where large scale testing had been done; some cases were uneventful, others had poor outcome. We report a case series from an universally tested population from Hospital Pedro Hispano, located in the most affected region of Portugal with COVID-19 [4]. From March 25 to April 15, all the 103 pregnant women admitted to our department were tested for SARS-CoV-2. Twelve cases (11,7 %) were positive, 11 of which were asymptomatic. From these, 10 had delivered by now, 6 by cesarean section and 4 vaginally. Gestational ages, 5 min Apgar scores and newborn weights ranged between 37–41 weeks, 9–10 and 2350–3380 g, respectively. Eight cases had mild fetal growth restriction and there was one delivery of twins. There were no maternal complications and all the newborns tested negative (Table 1 ).
Table 1

Summary of maternal characteristics, symptoms and delivery details of pregnant women with SARS-Cov-2 infection. Abbreviations: SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; RT‐PCR, reverse transcription polymerase chain reaction.

PatientAgeGestational age at diagnosis (weeks)Maternal comorbid conditionsSymptomsMode of deliveryFetus Weight (grams), Apgar score (1 min/5 min)Neonatal SARS-Cov-2 rt-PCRObservations
12235NoneNoFetal Growth Restriction
24130Ulcerative colitis, Psoriasis(chronic corticotherapy)NoPreterm Premature Rupture of Membranes.
33637Severe Scoliosis, Behçet SyndromeHeadacheCesarean2350 g, 9/10NegativeFetal Growth Restriction
43839NoneNoCesarean2480 g, 9/10NegativeGestational Diabetes, Fetal Growth Restriction
52741NoneNoCesarean3380 g, 9/10Negative
63237NoneNoVaginal2600 g, 8/9NegativeGestational Hypertension
73340Severe myopiaNoCesarean2670 g, 9/10NegativeFetal Growth Restriction
83440NoneNoVaginal2795 g, 9/10NegativeFetal Growth Restriction
93537Asthma, Raynaud SyndromeNoVaginal2410 g, 9/10NegativeFetal Growth Restriction
102739NoneNoVaginal3220 g, 9/10Negative
112938Chronic HypertensionNoCesarean2580 g, 9/10NegativeFetal Growth Restriction
122937NoneNoCesarean2370, 9/102745 g, 9/10NegativeNegativeDichorionic Diamniotic PregnancyFetal growth discordance
Summary of maternal characteristics, symptoms and delivery details of pregnant women with SARS-Cov-2 infection. Abbreviations: SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; RT‐PCR, reverse transcription polymerase chain reaction. Our series shows that most cases are asymptomatic. Not surprisingly, the prognosis was good in all our cases, as women had minimal or no signs of disease. Apparently, there is no relation between COVID-19 and our growth restricted fetuses, having in mind the chronology of the events. At the time of our first delivery, Portugal had decided to follow the most restrictive guidelines ultimately developed by Chinese experts [4,5]. The country was warned by the Italian and Spanish situations, where a devastating pandemic had started two weeks before and universal testing in hospital admissions was decided to allow early diagnosis and identification of potential spreaders of the disease. It is not yet known what is the best strategy to address COVID-19 during pregnancy and labor. However, it is quite clear that we do need to consider not only epidemiological and clinical factors, but also organizational, social and political issues. Last but not least, universal testing of all the admitted pregnant women is an unique opportunity to have an idea of the prevalence among the population (11,7 % in our series).

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  4 in total

1.  Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies.

Authors:  Mehreen Zaigham; Ola Andersson
Journal:  Acta Obstet Gynecol Scand       Date:  2020-04-20       Impact factor: 4.544

2.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

Authors:  Desmond Sutton; Karin Fuchs; Mary D'Alton; Dena Goffman
Journal:  N Engl J Med       Date:  2020-04-13       Impact factor: 91.245

3.  Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection.

Authors:  Dunjin Chen; Huixia Yang; Yun Cao; Weiwei Cheng; Tao Duan; Cuifang Fan; Shangrong Fan; Ling Feng; Yuanmei Gao; Fang He; Jing He; Yali Hu; Yi Jiang; Yimin Li; Jiafu Li; Xiaotian Li; Xuelan Li; Kangguang Lin; Caixia Liu; Juntao Liu; Xinghui Liu; Xingfei Pan; Qiumei Pang; Meihua Pu; Hongbo Qi; Chunyan Shi; Yu Sun; Jingxia Sun; Xietong Wang; Yichun Wang; Zilian Wang; Zhijian Wang; Chen Wang; Suqiu Wu; Hong Xin; Jianying Yan; Yangyu Zhao; Jun Zheng; Yihua Zhou; Li Zou; Yingchun Zeng; Yuanzhen Zhang; Xiaoming Guan
Journal:  Int J Gynaecol Obstet       Date:  2020-04-01       Impact factor: 4.447

4.  COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome.

Authors:  Enrico M Ferrazzi; Luigi Frigerio; Irene Cetin; Patrizia Vergani; Arsenio Spinillo; Federico Prefumo; Edda Pellegrini; Gianluigi Gargantini
Journal:  Int J Gynaecol Obstet       Date:  2020-06       Impact factor: 4.447

  4 in total
  22 in total

Review 1.  COVID-19 and Pregnancy: A narrative review of maternal and perinatal outcomes.

Authors:  Nihal Al Riyami; Shahila Sheik
Journal:  Sultan Qaboos Univ Med J       Date:  2022-05-26

2.  SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: Experience from COVID-19-dedicated maternity hospital in Jammu, Jammu and Kashmir (India).

Authors:  Puneet Gupta; Surender Kumar; Shashi S Sharma
Journal:  J Med Virol       Date:  2021-05-24       Impact factor: 20.693

Review 3.  The Profile of the Obstetric Patients with SARS-CoV-2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature.

Authors:  Yolanda Cuñarro-López; Pilar Pintado-Recarte; Ignacio Cueto-Hernández; Concepción Hernández-Martín; María Pilar Payá-Martínez; María Del Mar Muñóz-Chápuli; Óscar Cano-Valderrama; Coral Bravo; Julia Bujan; Melchor Álvarez-Mon; Miguel A Ortega; Juan Antonio De León-Luis
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

4.  Maternal and Neonatal Outcomes of COVID-19 in Pregnancy: A Single-Centre Observational Study.

Authors:  Vinita Singh; Anisha Choudhary; Mamta R Datta; Alokananda Ray
Journal:  Cureus       Date:  2021-02-06

5.  SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes.

Authors:  Asma Khalil; Erkan Kalafat; Can Benlioglu; Pat O'Brien; Edward Morris; Tim Draycott; Shakila Thangaratinam; Kirsty Le Doare; Paul Heath; Shamez Ladhani; Peter von Dadelszen; Laura A Magee
Journal:  EClinicalMedicine       Date:  2020-07-03

6.  COVID-19 in pregnancy: the foetal perspective-a systematic review.

Authors:  Rajani Dube; Subhranshu Sekhar Kar
Journal:  BMJ Paediatr Open       Date:  2020-11-25

7.  Routine screening for SARS CoV-2 in unselected pregnant women at delivery.

Authors:  Pilar Díaz-Corvillón; Max Mönckeberg; Antonia Barros; Sebastián E Illanes; Arturo Soldati; Jyh-Kae Nien; Manuel Schepeler; Javier Caradeux
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

8.  Clinical manifestations and perinatal outcomes of pregnant women with COVID-19: a systematic review and meta-analysis.

Authors:  Jeong Yee; Woorim Kim; Ji Min Han; Ha Young Yoon; Nari Lee; Kyung Eun Lee; Hye Sun Gwak
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

9.  A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: Clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity.

Authors:  Zohra S Lassi; Ali Ana; Jai K Das; Rehana A Salam; Zahra A Padhani; Omer Irfan; Zulfiqar A Bhutta
Journal:  J Glob Health       Date:  2021-06-30       Impact factor: 4.413

10.  COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission.

Authors:  Elicia Pettirosso; Michelle Giles; Stephen Cole; Megan Rees
Journal:  Aust N Z J Obstet Gynaecol       Date:  2020-08-10       Impact factor: 1.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.